(Q40739621)

23 September 2017

Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense (English)

1 reference

23 September 2017

Mautino MR

1

1 reference

PubMed ID

11938457

23 September 2017

Morgan RA

series ordinal

2

1 reference

23 September 2017

1 April 2002

1 reference

23 September 2017

1 reference

23 September 2017

9

1 reference

23 September 2017

7

1 reference

23 September 2017

421-431

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301674

23 September 2017

0 references

cites work

Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Anti-HIV effects of HIV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant Rev.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Production of high-titer helper-free retroviruses by transient transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

7 January 2021

Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

7 January 2021

HIV-1 genome nuclear import is mediated by a central DNA flap

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

7 January 2021

Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

7 January 2021

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

7 January 2021

Selection and characterization of human immunodeficiency virus type 1 mutants that are resistant to inhibition by the transdominant negative RevM10 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301674

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301674

1 reference

PubMed ID

11938457

Dimensions Publication ID

23 September 2017

0 references

1 reference

PubMed ID

11938457